Mechanism of the RNA helicase UPF1 regulatory loop in RNA decay target selection

Active Grant Awarded

Award ID
R15GM166980
Recipient
Awarding agency
Obligated
$396,941

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date 9% complete
Place of performance
Villanova, PA 19085, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services, National Institutes of Health, National Institute of General Medical Sciences awarded Villanova University in the State of Pennsylvania $396,941 on August 11, 2026, under Grant R15GM166980, funded through the Biomedical Research and Research Training program (CFDA 93.859). The award funds research into how the regulatory loop in the core of the RNA helicase UPF1 controls RNA target selection in nonsense-mediated decay (NMD), an RNA decay pathway. The project will generate a library of regulatory loop mutants and characterize their effects on UPF1 RNA binding and NMD substrate selection, using methods that range from in vitro helicase assays to genome-wide RNA-sequencing. Aim 1 determines how sequence, length, and structure of the regulatory loop modulate UPF1 binding to RNA in the presence of ATP.

The period of performance runs from August 11, 2026 through July 31, 2029, with performance at Villanova, PA 19085. The assistance type is a grant. The parent program supports basic research that advances understanding of biological processes and lays the foundation for disease diagnosis, treatment, and prevention.

Description

Abstract
Nonsense-mediated decay (NMD) is an RNA quality control pathway responsible for the elimination of defective transcripts that harbor premature termination codons as well as the regulated turnover of 5-10% of normal messenger rnas. An estimated one third of human genetic diseases are affected by NMD, yet there are no FDA-approved strategies to modulate this RNA decay pathway. This unmet need is due to our poor understanding of the basic mechanisms by which transcripts are selected for NMD and the step-by- step process by which substrates are decayed. Our long-term goal is to understand mechanisms of RNA target selection in NMD to modulate clinical outcomes associated with this RNA decay pathway. The objective of this proposal is to understand the mechanism by which a conserved structural element known as the regulatory loop in the core of the RNA helicase UPF1 controls target selection for the NMD pathway. Our central hypothesis is that the sequence, length, and structure of the regulatory loop are exquisitely tuned for modulating the association of UPF1 with RNA. The rationale behind this research objective is that, once IT is known how the UPF1 regulatory loop controls RNA decay target selection, we will use this understanding to design a system in which the function of UPF1 can be precisely modulated to control the fate of specific rnas for the NMD pathway in human cells. The central hypothesis will be tested by generating a library of regulatory loop mutants and characterizing the effects on UPF1 RNA binding and NMD substrate selection using methods that span from in vitro helicase assays to genome-wide investigations of RNA abundance by RNA-sequencing. In aim 1, the importance of regulatory loop architecture will be understood by determining how sequence, length, and structure modulate the binding of UPF1 to RNA in the presence of ATP. In aim 2, the function of the regulatory loop in controlling NMD target selection in response to a complex cellular environment will be determined. In aim 3, the extent to which the regulatory loop modulates activation of UPF1 by its cofactor UPF2 will be elucidated. The proposed research is significant because IT is expected to provide a mechanism for UPF1 target selection in NMD and offer new horizons for how this knowledge can be used to modulate the fate of specific rnas for this decay pathway in human cells. This work is broadly applicable for understanding many mechanisms by which RNA helicases govern gene regulatory pathways on which to continue future research.

Quick answers

Who received award R15GM166980?

R15GM166980 was awarded to Villanova University In The State Of Pennsylvania by National Institute of General Medical Sciences (National Institutes of Health) on August 11, 2026.

How much is award R15GM166980 worth?

$396,941 has been obligated on R15GM166980.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award